Yep Grouse, and I want to see colossal revenue growth over the next several quarters that proves via multiple blockbusting commercialization partnerships that VYST has a competitive advantage proprietary pipeline of products companies want!
It's irrelevant to me how VYST never broke through in the pre-Rotmans financial foundation days! All that's relevant now & moving forward is how many commercialization era partners VYST's officially on the verge of transitioning out of extensive trials/talks into commercial scale partnerships right!
And a follow up announcement to this weeks table setting news revealing the major healthcare manufacturer willing to invest $3M to $5M in real deal investment monies to secure a 51% majority ownership stake in the upcoming new RxAir Inc. spinoff PubCo to have the exclusive rights to unlock the inherent potential in the UV400 units will be an excellent start!
As nobody predicted that VYST's BOD's were even coming up with such a creative and ingenious way to secure their 1st commercialization major manufacturer on any of the products in their pipeline! I know I sure wasn't, as I still remain convinced that VYST has multiple Vytex commercialization partners coming over the near term horizon too!
So bring on the healthcare manufacturer, the Super 8k, and all the other fresh & impactful valuation driving catalysts VYST's CEO is preparing to rollout, and let's see how rapidly VYST can move up to the QX from the QB, as clearly VYST's BOD's are following a growth blueprint much further along than the majority of the market masses yet realize.
And quite frankly some of the blue chip darlings embark on paths of rapid and colossal revenue growth b4 even worrying about attaining profitability...as the key for VYST's biz curve success is proving that their proprietary product pipeline has the propensity to win over multiple big fish commercialization partners, which they're gonna take a big step towards proving by releasing the healthcare manufacturer referenced in this weeks dividend spin off table setting news!
And there's very good reason several blue chip stars like Uber, Wayfair and countless others focused on maximizing their potential revenue growth curve to its full extent because they know penetrating and capturing market share and rapidly increasing revenue growth was gonna get rewarded and put them on the road to great success and achieve household name status!
And at this exact juncture VYST is definitely entering their initial post Rotmans leverage commercialization era, which the market's gonna measure them by whenever CEO Rotman starts the initial dominos flowing directly ahead!
And with all the 3rd party convertible aged debt eliminated off the books prior to their optimal commercialization era financial foundation even being officially completed, and so many commons already locked up in insider hands, CEO Rotmans and VYST's BOD's creative options for dramatically improving VYST's capital structure become a key underlying market driver of the oncoming new valuation metrics which will soon be getting applied here. Because if there is in fact a significant share exchange from commons to preferred simultaneous with their long anticipated/awaited share repurchase program while the initial half dozen commercialization partners are unveiled...this stock is going to ascend onto the QX at record speed and put VYST on everyone's radar. And no-one can claim that the ingredients are not there for VYST to adopt such a simultaneous creative capital structure and commercialization strategy if that's the pathway they embark on! And why wouldn't VYST's insiders agree to a dramatic and impactful share exchange anyways? Because it directly benefits them to vastly improve VYST's share structure just as much as the market, especially if they're as serious about achieving CEO Rotman's Nasdaq up listing objective as their ongoing collective insider ownership positions clearly reflect!
So it's definitely going to be an interesting next few weeks now through American Thanksgiving! Because all VYST's CEO has to do now is start unleashing his long slumbering VYST BEAST and proving to the market that they're ready to hit the ground running and rapidly escalate to a $100M, then $200M and $300M market cap based entirely on the real & verifiable power behind their 1st handful or half dozen commercialization partnerships directly ahead!
And if CEO Rotman does in fact deliver the 1st handful or half dozen commercialization era deals by/b4 the end of this year while simultaneously improving VYST's capital structure and securing an investment banking dance partner to go on their growth journey. This 4th quarter of 2019 will forever get looked back upon as the timeframe when all the VYST stars finally aligned on 1 of the years most explosive OTC BEASTS after several months of meticulous planning and creative juices flowing to launch VYST's commercialization era from the most rock solid financial foundation possible>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
News 
Market Data 
Discover 
